LATE-NC in Alzheimer's disease: Molecular aspects and synergies

被引:5
|
作者
Tome, Sandra O. [1 ,2 ]
Gawor, Klara [1 ,2 ]
Thal, Dietmar Rudolf [1 ,2 ,3 ]
机构
[1] Katholieke Univ Leuven, Dept Imaging & Pathol, Lab Neuropathol, Leuven, Belgium
[2] Katholieke Univ Leuven, Leuven Brain Inst, Leuven, Belgium
[3] Univ Hosp Leuven, Dept Pathol, Leuven, Belgium
关键词
Alzheimer's disease; LATE-NC; tau; TDP-43; DNA-BINDING PROTEIN; FRONTOTEMPORAL LOBAR DEGENERATION; HIPPOCAMPAL SCLEROSIS; TDP-43; PATHOLOGY; COGNITIVE DECLINE; BRAIN-REGIONS; DEMENTIA; TAU; ENCEPHALOPATHY; IMMUNOREACTIVITY;
D O I
10.1111/bpa.13213
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Alzheimer's disease (AD) is classically characterized by senile plaques and neurofibrillary tangles (NFTs). However, multiple copathologies can be observed in the AD brain and contribute to the development of cognitive decline. Limbic-predominant age-related TDP-43 encephalopathy neuropathological changes (LATE-NC) accumulates in the majority of AD cases and leads to more severe cognitive decline compared with AD pathology alone. In this review, we focus on the synergistic relationship between LATE-NC and tau in AD, highlighting the aggravating role of TDP-43 aggregates on tau pathogenesis and its impact on the clinical picture and therapeutic strategies. Additionally, we discuss to what extent the molecular patterns of LATE-NC in AD differ from frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP) neuropathological changes. Thus, we highlight the importance of tau and TDP-43 synergies for subtyping AD patients, which may respond differently to therapeutic interventions depending on the presence of comorbid LATE-NC.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Molecular Approaches to the Treatment, Prophylaxis, and Diagnosis of Alzheimer's Disease: Clinical Molecular and Genetic Studies on Alzheimer's Disease
    Shoji, Mikio
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 118 (03) : 345 - 349
  • [32] Molecular interaction of stress granules with Tau and autophagy in Alzheimer's disease
    Yu, Qin-Yuan
    Ye, Ling-Qi
    Li, Hong-Lei
    NEUROCHEMISTRY INTERNATIONAL, 2022, 157
  • [33] Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease
    Spina, Salvatore
    La Joie, Renaud
    Petersen, Cathrine
    Nolan, Amber L.
    Cuevas, Deion
    Cosme, Celica
    Hepker, Mackenzie
    Hwang, Ji-Hye
    Miller, Zachary A.
    Huang, Eric J.
    Karydas, Anna M.
    Grant, Harli
    Boxer, Adam L.
    Gorno-Tempini, Maria Luisa
    Rosen, Howard J.
    Kramer, Joel H.
    Miller, Bruce L.
    Seeley, William W.
    Rabinovici, Gil D.
    Grinberg, Lea T.
    BRAIN, 2021, 144 : 2186 - 2198
  • [34] Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease
    Hu, William T.
    Chen-Plotkin, Alice
    Arnold, Steven E.
    Grossman, Murray
    Clark, Christopher M.
    Shaw, Leslie M.
    McCluskey, Leo
    Elman, Lauren
    Karlawish, Jason
    Hurtig, Howard I.
    Siderowf, Andrew
    Lee, Virginia M. -Y.
    Soares, Holly
    Trojanowski, John Q.
    ACTA NEUROPATHOLOGICA, 2010, 120 (03) : 385 - 399
  • [35] Molecular aspects of neurodegeneration in Alzheimer's disease
    Russo, C
    Venezia, V
    Salis, S
    Dolcini, V
    Schettini, G
    FUNCTIONAL NEUROLOGY, 2002, 17 (02) : 65 - 70
  • [36] Topical Cellular/Tissue and Molecular Aspects Regarding Nonpharmacological Interventions in Alzheimer's Disease-A Systematic Review
    Aurelian, Sorina
    Ciobanu, Adela
    Carare, Roxana
    Stoica, Simona-Isabelle
    Anghelescu, Aurelian
    Ciobanu, Vlad
    Onose, Gelu
    Munteanu, Constantin
    Popescu, Cristina
    Andone, Ioana
    Spinu, Aura
    Firan, Carmen
    Cazacu, Ioana Simona
    Trandafir, Andreea-Iulia
    Baila, Mihai
    Postoiu, Ruxandra-Luciana
    Zamfirescu, Andreea
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (22)
  • [37] Frequency of LATE neuropathologic change across the spectrum of Alzheimer's disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts
    Nelson, Peter T.
    Brayne, Carol
    Flanagan, Margaret E.
    Abner, Erin L.
    Agrawal, Sonal
    Attems, Johannes
    Castellani, Rudolph J.
    Corrada, Maria M.
    Cykowski, Matthew D.
    Di, Jing
    Dickson, Dennis W.
    Dugger, Brittany N.
    Ervin, John F.
    Fleming, Jane
    Graff-Radford, Jonathan
    Grinberg, Lea T.
    Hokkanen, Suvi R. K.
    Hunter, Sally
    Kapasi, Alifiya
    Kawas, Claudia H.
    Keage, Hannah A. D.
    Keene, C. Dirk
    Kero, Mia
    Knopman, David S.
    Kouri, Naomi
    Kovacs, Gabor G.
    Labuzan, Sydney A.
    Larson, Eric B.
    Latimer, Caitlin S.
    Leite, Renata E. P.
    Matchett, Billie J.
    Matthews, Fiona E.
    Merrick, Richard
    Montine, Thomas J.
    Murray, Melissa E.
    Myllykangas, Liisa
    Nag, Sukriti
    Nelson, Ruth S.
    Neltner, Janna H.
    Nguyen, Aivi T.
    Petersen, Ronald C.
    Polvikoski, Tuomo
    Reichard, R. Ross
    Rodriguez, Roberta D.
    Suemoto, Claudia K.
    Wang, Shih-Hsiu J.
    Wharton, Stephen B.
    White, Lon
    Schneider, Julie A.
    ACTA NEUROPATHOLOGICA, 2022, 144 (01) : 27 - 44
  • [38] Advances in nanoprobes for molecular MRI of Alzheimer's disease
    Parekh, Parag
    Badachhape, Andrew A.
    Tanifum, Eric A.
    Annapragada, Ananth V.
    Ghaghada, Ketan B.
    WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2024, 16 (02)
  • [39] Molecular Therapeutics in Development to Treat Alzheimer's Disease
    Tartaglia, Maria Carmela
    Ingelsson, Martin
    MOLECULAR DIAGNOSIS & THERAPY, 2025, 29 (01) : 9 - 24
  • [40] Alzheimer's disease research in the context of the national plan to address Alzheimer's disease
    Snyder, Heather M.
    Hendrix, James
    Bain, Lisa J.
    Carrillo, Maria C.
    MOLECULAR ASPECTS OF MEDICINE, 2015, 43-44 : 16 - 24